Objectives: Fast and accurate diagnostic tests to identify carbapenemase-producing Enterobacteriaceae (CPE) are mandatory for proper antimicrobial therapy and implementing infection control measures. Here, we have developed a rapid Carbapenem Inactivation Method (rCIM) for CPE detection.
Introduction
Infections caused by carbapenem-resistant Enterobacteriaceae (CRE) are increasingly reported worldwide, [1] [2] [3] [4] leading to significantly higher mortality rates and increased healthcare costs. [5] [6] [7] Resistance to carbapenems can stem from production of carbapenemases or other mechanisms such as decreased permeability, overproduction of ESBLs or cephalosporinases, efflux pumps or combinations of these mechanisms. 8 Carbapenemase-producing Enterobacteriaceae (CPE) are the most worrisome, as they leave clinicians with limited therapeutic options, owing to their hydrolytic spectrum as well as the associated resistance to other antibiotic classes and because of their propensity to spread rapidly in healthcare settings. 9 In addition, as carbapenemase genes are frequently located on mobile genetic elements and plasmids, they can be transferred to other bacteria. 10, 11 CPEs were initially reported in hospitals but, in recent years, the problem has emerged also in the community. 12 The existence of CPEs outside the hospital raises major concerns regarding the future of infection control, as it may speed up the spread to the general population. For antibiotic stewardship and infection control measures to be effective, rapid, reliable and cost-effective tests are required to detect CPE carriers or infections. Various phenotypic CPE detection tests have been developed, including inhibition tests of carbapenemase activity, 13, 14 detection of carbapenem hydrolysis using MALDI-TOF MS, 15 biochemical tests (e.g. Carba NP test and derivatives) 16, 17 and the carbapenem inactivation method (CIM). 18 These tests can detect the presence of a carbapenemase and sometimes discriminate between Ambler class A and Ambler class B carbapenemases (e.g inhibition tests and Carba NP test II and OXA-48 Disk Test). 14, 19 Immunochromatographic assays, aiming to detect OXA-48-like, IMP-like and OXA-48/KPC CPEs from solid cultures have shown their usefulness in rapid detection of these carbapenemases. [20] [21] [22] Finally, molecular methods remain the gold standard for the detection of carbapenemase producers. 13, [23] [24] [25] Most commercially available molecular tools target only the five most prevalent carbapenemases and thus miss minor carbapenemases (GES, IMI, SME, etc.).
Here, we describe the rapid Carbapenem Inactivation Method (rCIM), an improved variant of the CIM, which brings down the CPE detection time from more than 24 h, to less than 3 h.
Materials and methods

Bacterial isolates and antibiotic susceptibility testing
A retrospective study of well-characterized enterobacterial strains from the collection of the French National Reference Center (NRC) for Antimicrobial Resistance was used to evaluate the rCIM and to determine the operating characteristics of the test. The strains were subcultured from the frozen stock (stored at -80 C) on UriSelect TM 4 (BioRad, Marne-la-Coquette, France) for 24 h at 37 C. The collection included 113 well-characterized carbapenem-resistant isolates, of which 85 were carbapenemase producers and 28 non-carbapenemase producers. The CPEs included 19 class A producers (10 KPCs, 3 IMIs, 2 GESs, 1 FRI-1, 2 SMEs and 1 NmcA) as well as 27 class B producers (12 NDMs, 8 VIMs, 6 IMPs and 1 GIM), and 39 class D producers (17 OXA-48s and 22 OXA-48 variants, including lowhydrolysing enzymes such as OXA-181 and OXA-244). 26, 27 MICs of carbapenems were determined using the Etest (bioMérieux, La Balmes les Grottes, France) and results were interpreted following EUCAST guidelines, as updated in 2016 (http://www.eucast.org). 26 For the prospective study, all the isolates received by the NRC for CRE testing over a period of two weeks were included. Upon receipt by the NRC, enterobacterial isolates were cultured on UriSelect TM 4 (BioRad) for 24 h at 37 C to assess their purity. Routine disc diffusion antibiograms were performed and interpreted according to EUCAST guidelines.
Carbapenemase activity detection
The CIM was performed as previously described. 18, 26 It consists of suspending a 10 lL loopful of bacteria in 400 lL of sterile water with one 10 lg meropenem disc and incubating for 2 h. The disc is then placed on a plate seeded with Escherichia coli ATCC 25922 and re-incubated for 18 h. If the strain is a carbapenemase producer, then the antibiotic in the disc is inactivated and leads to the appearance of a markedly diminished zone of inhibition (most frequently growth to the edge of the disc). The home-made Carba NP test was performed as previously described. 19 The rCIM is derived from the CIM. 18, 26 Two 10 lL loopfuls of an overnight culture taken from solid media were homogenized into an Eppendorf tube containing 1 mL of sterile water. Two meropenem discs (Oxoid, UK) were added to the suspension and vortexed for 1 min. This allows for the diffusion of the meropenem from the discs into the suspension. The Eppendorf tube was incubated for 30 min at 37 C, subsequently vortexed for an additional minute, and then centrifuged for 5 min at 10 000 rpm (for highly mucoid strains, a second centrifugation step may be needed). Fivehundred lL of the supernatant was added to 2500 lL of an E. coli ATCC 25922 resuspended in trypticase soy broth (bioMérieux, France) at a McFarland index of 1 (DEN-1B nephelometer, BioSan, Latvia). The tubes were incubated at 37 C for 2 h with a nephelometer reading taken every 30 min to assess the growth of the indicator E. coli strain. Growth was expressed as baseline-subtracted growth in McFarland units. Positive and negative controls of Klebsiella pneumoniae ATCC BAA-1705 and BAA-1706, respectively, were used for each batch of tests.
rCIM repeatability
Repeatability of the rCIM was assessed through repeat testing of 10 carbapenemase-producing isolates from each Ambler class, as well as 10 isolates that were carbapenem resistant through other mechanisms. Technical replicates were done for each of the strains from overnight solid culture.
Molecular identification of the carbapenemase genes
An in-house PCR was performed as previously described. 26, 28 The targeted carbapenemase genes were bla OXA-48-like , bla KPC-like , bla NDM-like , bla IMP-like , bla IMI-like , bla VIM-like and bla GES-like . PCR products were sequenced using an automated Applied Biosystems sequencer (ABI PRISM 3100, Les Ullis, France).
Statistical analysis
The sensitivity, specificity and positive and negative predictive values were calculated, with their respective 95% CI, using the R v. 3.4.1 software suite and epiR v. 0.9-87. Test sensitivities and specificities were compared using McNemar's v 2 test from the base R package. The gold standard was PCR followed by sequencing.
Results and discussion
Validation and definition of a positivity cut-off
To establish the uninhibited growth of the E. coli indicator strain, mock challenge experiments were carried out with distilled water and growth was recorded every 30 min. To account for possible carry-over, we also performed experiments with centrifuged bacterial suspensions, without the addition of antibiotic discs. A similar strategy was undertaken for the negative controls, using incubated antibiotic discs and the E. coli indicator strain to account for carry-over. Carry-over was quantified by measuring the McFarland index before and after the supernatant challenge. This was found to be minimal, with a mean (+SD) value of -0.02 (+0.12) McFarland units. Furthermore, the use of chromogenic medium (colour of bacterial colonies) did not influence the reading of the results.
In the presence of inactivated antibiotic, the indicator strain could grow unhindered, with median (min-max) baselinesubtracted growth at 1.5 and 2 h reaching 0.86 (0.84-0.89) and 1.34 (1.31-1.37), respectively. In the negative controls, growth at 1.5 and 2 h was 0.15 (0.12-0.17) and #0.02 (#0.05-0), respectively. Growth differences in positive and negative controls were not significantly different before 1.5 h, owing to residual indicator strain growth. We established a cut-off of 0.5 McFarland units as an a priori positive test and evaluated this hypothesis rCIM for rapid CPE detection JAC retrospectively on a collection of well-characterized enterobacterial isolates with reduced susceptibility to at least one carbapenem.
Test repeatability
To assess the reliability of the test we performed a repeatability analysis, including 10 strains from each of the carbapenemase Ambler classes as well as 10 non-carbapenemase-producing strains. The isolates comprised 1 Citrobacter koseri, 1 Enterobacter asburiae, 1 Morganella morganii, 4 Serratia marcescens, 7 Enterobacter cloacae, 8 E. coli and 18 K. pneumoniae, harbouring class A (FRI-1, GES-5, IMI-1, IMI-2, KPC-2, SME-1, SME-2), class B (GIM-1, IMP-1, IMP-4, IMP-11, NDM-1, NDM-4, VIM-1, VIM-2, VIM-19) or class D (OXA-48, OXA-162, OXA-181, OXA-244) and 10 noncarbapenemase producers (Table 1) .
Overall, the repeatability was excellent, with the exception of low-hydrolysing strains and strains requiring induction of their b-lactamase. Two IMI-like-expressing strains, an E. asburiae and an E. cloacae, gave 2 out of 3 positive results with rCIM. A GES-5 K. pneumoniae strain tested positive 2 out of 3 times.
Retrospective analysis Table 2 ). In contrast, when challenged with active antibiotic, the median growth was of 0. 13 McFarland units (range #0.13 to 0.47, IQR 0.05-0.22). One E. cloacae strain with cephalosporinase hyperproduction initially tested positive, and then tested negative twice.
Thus, the sensitivity of the rCIM was 99% (95% CI 94%-100%) and the specificity was 100% (95% CI 88%-100%), using a simple indicator of baseline-subtracted growth of 0.5 McFarland units at 2 h. Using the same panel of isolates, the sensitivity and the specificity of the CIM test were 94% (95% CI 87%-98%) and 100% (95% CI 88%-100%), respectively. Among the undetected strains, there was one NDM-1-producing Providencia rettgeri, two OXA-244-producing E. coli, one VIM-4-and one VIM-2-producing E. cloacae. The Carba NP test had a sensitivity of 93% (95% CI 85%-97%) and a specificity of 100% (95% CI 88%-100%). The false-negative isolates were the three OXA-244-producing E. coli, one VIM-4-and one VIM-2-producing E. cloacae, and an IMI-2-producing E. asburiae (Table 3) .
Prospective rCIM evaluation
The 101 isolates of the prospective study included 34 K. pneumoniae, 23 E. coli, 21 E. cloacae, 12 Citrobacter freundii, 2 E. asburiae, 2 Proteus mirabilis, 2 P. rettgeri, 1 Providencia stuartii, 1 Citrobacter youngae, 1 Enterobacter hormaechei, 1 Hafnia alvei and 1 M. morganii. They expressed 45 OXA-48-like, 10 NDM-like, 5 VIM-like, 2 KPC-like and 2 IMI-like enzymes, 15 hyperproduced cephalosporinases, 12 ESBLs, 4 hyperproduced cephalosporinase and an ESBL and 6 others had non-enzymatic carbapenem resistance 
NA, not applicable, as these bacteria produce no carbapenem-hydrolysing enzymes. All of these strains had decreased permeability and either an ESBL or an overexpressed cephalosporinase.
mechanisms. After WGS, the two IMI-like-producing E. asburiae were identified as being the same strain, producing a novel IMI variant (submitted to GenBank under the name IMI-17), and was counted only once. Thus, there were 100 isolates tested in total. PCR sequencing results are displayed in Table 4 . Using the cut-off defined in the retrospective study, the sensitivity of the rCIM was 98% (95% CI 89%-99%) and the specificity was 95% (95% CI 82%-99%), with a positive predictive value of 97% (95% CI 89%-100%) and a negative predictive value of 97% (95% CI 85%-100%). Two cephalosporinasehyperproducing E. cloacae isolates gave false-positive results, while a novel IMI variant-producing E. asburiae gave a falsenegative result (Figure 2 ).
In combination with the interpretative reading of the antibiogram, the Carba NP test is used as the reference method for the screening of carbapenemase activity at the French NRC. It had a sensitivity of 92% (95% CI 82%-97%), a specificity of 100% (95% CI 91%-100%), a positive predictive value of 100% (95% CI 89%-100%) and a negative predictive value of 88% (95% CI 74%-96%). A total of four strains tested Carba NP negative. These were an OXA-181-producing E. coli, the novel IMI variantexpressing E. asburiae, one NDM-1-producing P. rettgeri and one NDM-1-producing P. stuartii.
The rCIM showed better sensitivity than the Carba NP test (98% versus 92%, P " 0.01), with the trade-off of a lower specificity (95% versus 100%, P , 0.001).
rCIM false-negative results
Even though a low positivity cut-off was chosen in order to ease the detection of low carbapenem-hydrolysing enzymes, such as OXA-244, 27 three isolates gave false-negative rCIM results (1.6%): two OXA-244-producing E. coli strains and an E. asburiae producing a novel IMI variant (IMI-17). One of the OXA-244 isolates was positive on repeated testing (2!/1#) while the two others tested negative when taken directly off the UriSelect TM 4 medium. OXA-244 enzymes are difficult to detect, as recently shown by Hoyos-Mallecot et al. 27 These enzymes are characterized by weak carbapenem hydrolysis that results in reduced susceptibility to carbapenems only. However, as OXA-244 may be plasmid encoded, horizontal gene transfer may occur into bacteria with impaired outer membrane permeability, and lead to high-level carbapenem resistance. 29, 30 Thus, it is of outmost importance to identify these enzymes using proper diagnostic algorithms (i.e. the use of temocillin resistance as a marker for OXA-48-like carbapenemases) and rapid diagnostic tests. 31, 32 The rCIM seems to be an excellent test in this respect, as six out of the seven OXA-244-producing E. coli isolates were correctly identified as carbapenemase producers.
In the case of the E. asburiae isolate, the false-negative rCIM results could be explained by the low level and inducible nature of IMI production. These enzymes can be induced with imipenem or cefoxitin through the presence of the LysR-type regulator IMI-R. 33 The IMI-producing E. asburiae isolate was negative with rCIM, Carba NP and CIM tests when grown on UriSelect TM 4 media. When the isolate was grown on Mueller-Hinton or on selective chromogenic media, such as CarbaSmart (bioMérieux), it gave a positive rCIM result.
rCIM false-positive results
Overall, the rCIM gave three false-positive isolates (1.6%); all corresponded to cephalosporinase-hyperproducing E. cloacae. One of them, in the retrospective study, proved negative on repeated testing (2#/1!). The two other isolates were from the prospective study and grew slightly above the baseline-subtracted McFarland threshold of 0.5 (0.89 and 1.29, respectively); on repeat testing, one gave consistent results over the 0.5 McFarland threshold (3!), while one gave mostly negative results (2#/1!). Laboratories have to keep in mind that cephalosporinase-hyperproducing E. cloacae may provide weak positive results and thus would require additional testing.
Practical guidance
In high incidence settings, the rCIM might be used to rapidly confirm the presence of a carbapenem-hydrolysing enzyme in various enterobacterial isolates. The rCIM can be interpreted after 1.5 h of indicator strain growth (roughly 2 h of total preparation). In our total experience of testing 213 isolates, a baseline-subtracted growth of more than 1 is highly indicative of carbapenemase production (131/148 CPEs and 1 false-positive isolate). For baseline-subtracted growth between 0.5 and 1, 30 min of additional incubation was beneficial, as nine other CPE isolates (140/148) were detected (Figure 3) .
At 2 h, isolates with baseline-subtracted growth between 0.5 and 1 should undergo further testing (using molecular or immune-enzymatic assays, such as the OKN K-SeT assay), 34 rCIM for rapid CPE detection JAC Table 2 . Results from the retrospective study, showing agreement and differences between the rCIM, Carba NP and CIM for a well-characterized set of Enterobacteriaceae
or even retesting. Of all the carbapenemase producers tested, only OXA-244, KPC-2 and IMI-2 producers (n " 7) gave such results. Another isolate, an E. cloacae hyperproducing a cephalosporinase, also gave an indeterminate result. Once the antibiograms are obtained, phenotypic interpretation of the antibiogram and retesting from the Mueller-Hinton plate may clarify certain borderline cases, especially with IMI producers. In the absence of carbapenemase production, 63 out of 65 isolates were identified at 2 h. In 2016, the French NRC received 2839 carbapenem-resistant strains, of which 1551 harboured a carbapenemase. Class D carbapenemases were by far the most frequent, forming about three-quarters of the total number of isolates sent in for expert assessment (1187/1551; 76%). Of these, the majority were OXA-48 (n " 1078) and OXA-181 producers (n " 73). OXA-244 producers (n " 8) represented only 0.5% of the total carbapenemase producers. The epidemiology of strains tested in our prospective study mirror the national epidemiology. Of interest, one OXA-181 isolate tested in the prospective study was positive with rCIM but repeatedly negative with the Carba NP test. Class B carbapenemases follow at a distance (282/1551; 18%), with NDM-type enzymes predominating (n " 217), followed by VIM-type enzymes (n " 62), and very rarely IMP enzymes (n " 3). All these enzymes were accurately identified with all three phenotypic tests. Class A carbapenemases are relatively rare and account for less than 5% (53/1551). Of note, the IMI-type enzymes are very rarely isolated and represented less than 1% (14/1551) of the cases identified by the NRC. Lastly, some strains sent to the NRC expressed multiple carbapenemases. Thus, in daily clinical practice, the sensitivity of the rCIM would probably be even higher.
One limit of the current study is the use of a set of conditions including incubation in sterile water and the use of trypticase soy broth media for the growth of the indicator. As a result, outcomes might differ when other buffers or broths might be used (e.g. Tris-buffered saline or Mueller-Hinton). Trypticase soy broth was chosen because it is a general-purpose nutritive medium, cheaper than Mueller-Hinton and should be more readily available to laboratories. Furthermore, the rCIM requires multiple hands-on steps (including multiple incubation steps and centrifugation), which should be taken into account when comparing with other commercial methods (Carba NP and b-Carba Test). We acknowledge that the extra hands-on time might increase the time-toresult, though we feel that this remains similar as compared with other methods. Lastly, the need for a big inoculum (two 10 lL loops) needs to be addressed as a limiting factor as large quantities of bacteria are not always recovered from screening media.
Recently, another variation of the CIM, the mCIM, was published, showing good inter-laboratory agreement, 35, 36 but with the same drawback of the 24 h time frame necessary for detection. The rCIM resolves this major problem, requiring less than 3 h of total work time, which is compatible with the daily practice of a clinical microbiology laboratory.
Compared with the Carba NP, the rCIM offers a more objective perspective of interpretation as it is a quantitative test. This may make it easier for laboratory personnel to quantify uncertainty and use additional tests, as appropriate. 
Grey shading indicates unexpected results (either false-positive or false-negative testing results). rCIM for rapid CPE detection
JAC
The cost of the rCIM is very low, comparable to the CIM and mCIM. 18, 26, 35 Using the online prices from a major French distributor, we estimated the costs for the rCIM to be $0.13 for 3 mL of trypticase soy broth ! $0.096 for two antibiotic discs (Table 5) .
Unlike the CIM and mCIM, the rCIM does not require the manipulation of contaminated antibiotic discs with highly drug-resistant bacteria, eliminating the potential of cross-contamination. On the other hand, the rCIM requires the use of a nephelometer and a 
Case, overexpressed cephalosporinase. Grey shading indicates unexpected results (either false-positive or falsenegative testing results). centrifuge, but we expect that these would be present in the vast majority of laboratories.
Conclusions
Overall, the high sensitivity and specificity of rCIM, as well as the fact that is a rapid test, make it a useful tool in clinical microbiology laboratories. The rCIM does not need trained personnel and the equipment needed is largely present in most microbiology laboratories worldwide. The rCIM resolves the main limitation of the CIM as it can provide same-day results, thus being able to guide the clinician regarding the treatment and making it compatible with efficient implementation of infection control measures.
In conclusion, the rCIM is a quantitative test that has a price comparable with that of CIM and mCIM (,$1 per test) and a detection time comparable with that of Carba NP, making it accessible even in small laboratories.
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